Weam Aldiban: The Critical Impact of Pharmacogenetic Variation on Dabigatran Exposure and Bleeding Risk
Weam Aldiban, Head of Pharmacology & Toxicology Department at IUST University, shared a post on LinkedIn:
“Excited to share our latest publication in Human Genomics!
Title: The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis
Our study highlights the critical impact of pharmacogenetic variation on dabigatran exposure and bleeding risk. Key findings include:
– ABCB1 rs/148738 CT/TT genotypes → lower trough concentrations
– CES1 rs8192935 GG genotype → increased peak concentrations
– CES1 rs2244613 TT genotype → elevated peak/trough levels and bleeding risk
– CES1 rs2244613 GT genotype → increased trough levels only
These insights underscore the importance of personalized medicine in anticoagulant therapy and call for large-scale prospective studies across diverse populations to validate and expand upon our findings.
Grateful to our team and collaborators for their dedication and rigor. Let’s keep pushing the boundaries of precision pharmacotherapy!”
Title: The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis
Authors: Weam Aldiban, Nada G. Hamam, Nereen A. Almosilhy, Kholoud Elsamman, Mohamed Wagdy, Doaa Mashaly, Suhel F. Batarseh, Youssef El-Sherif, Basma Badrawy Khalefa, Zina Otmani
Read full paper here.
Stay informed with Hemostasis Today.
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 16:24Emerging Advances in Transfusion Medicine from AI to Genomic Blood Typing – ASH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research
-
Feb 20, 2026, 15:49David Smadja: Exploring Endothelial Biology and Hemostasis for Innovation in Patient Care
-
Feb 20, 2026, 15:08Maria Cherska: Insights from EAS 2025 on Detection and Long-Term Management of FH